News2018-12-20T15:03:55+00:00

NEWS

Umeåföretag tar nästa steg mot ett nytt läkemedel

March 6th, 2019|

PRESSMEDDELANDE 2019-03-06 Ladda ned pressrelase: Investerare satsar 25 MSEK på nytt läkemedel (pdf) » Umeåföretaget Lipum utvecklar ett biologiskt läkemedel för behandling av kroniska inflammationer. Tidigare pre-kliniska studier har visat mycket goda resultat och potential [...]

Lipum to NASDAQ

March 4th, 2019|

On 6-7 March, Lipum attends a pitching event for Deep Tech companies in Stockholm hosted by The European Innovation Council (EIC) pilot and Nasdaq. The event is exclusively organised for EIC pilot- funded companies with [...]

Lipum makes a share issue for faster progress

January 17th, 2019|

Being a European Commission Horizon 2020 beneficiary has a distinct positive impact on our development. The 2.2 M€ grant enables us to proceed faster towards a new drug against chronic inflammatory diseases. To further increase [...]

RECENT POSTS